Benefits of medical treatment of obesity. by Aveyard, P

The neurobiological basis for partial agonist treatment of nicotine dependence. by Aveyard, P

Motivational interviewing for smokers. by Aveyard, P

A commentary on 'exercise and smoking cessation (Ussher et al, 2012): And the verdict is...' by Aveyard, P

The place of varenicline in smoking cessation treatment. by Aveyard, P

Non-tailored computer-generated letters encourage smokers to quit by Aveyard, P

Prevention in practice: why is it neglected and what can we do? by Aveyard, P, Jebb, S

Rebuttal from Rachna Begh and Paul Aveyard by Begh, R, Aveyard, P

Waterpipe smoking in students: Prevalence, risk factors, symptoms of addiction, and smoke intake. Evidence from one British university by Jackson, D, Aveyard, P

New York City offensive against tobacco. by Murphy, M, Aveyard, P

Does exercise in adolescence prevent smoking uptake? by Aveyard, P, Ussher, M

Cytisine and the failure to market and regulate for human health. by Aveyard, P, West, R

Managing smoking cessation. by Aveyard, P, West, R

CrossTalk proposal: The benefits of e-cigarettes outweigh the harms by Begh, R, Aveyard, P

Authors' reply to letter [6] by Aveyard, P, West, R

Authors' reply by Aveyard, P, Munafo, M

Provision of smoking cessation support in UK primary care: impact of the 2012 QOF revision. by Szatkowski, L, Aveyard, P

Provision of commercial weight management programmes. by Jolly, K, Aveyard, P

'Willpower' is not enough: time for a new approach to public health policy to prevent obesity by Jebb, SA, Aveyard, P

Incentives for promoting smoking cessation: What we still do not know. by Aveyard, P, Bauld, L